Literature DB >> 23085373

Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases.

Bhopal Mohapatra1, Gulzar Ahmad, Scott Nadeau, Neha Zutshi, Wei An, Sarah Scheffe, Lin Dong, Dan Feng, Benjamin Goetz, Priyanka Arya, Tameka A Bailey, Nicholas Palermo, Gloria E O Borgstahl, Amarnath Natarajan, Srikumar M Raja, Mayumi Naramura, Vimla Band, Hamid Band.   

Abstract

Protein tyrosine kinases (PTKs) coordinate a broad spectrum of cellular responses to extracellular stimuli and cell-cell interactions during development, tissue homeostasis, and responses to environmental challenges. Thus, an understanding of the regulatory mechanisms that ensure physiological PTK function and potential aberrations of these regulatory processes during diseases such as cancer are of broad interest in biology and medicine. Aside from the expected role of phospho-tyrosine phosphatases, recent studies have revealed a critical role of covalent modification of activated PTKs with ubiquitin as a critical mechanism of their negative regulation. Members of the Cbl protein family (Cbl, Cbl-b and Cbl-c in mammals) have emerged as dominant "activated PTK-selective" ubiquitin ligases. Structural, biochemical and cell biological studies have established that Cbl protein-dependent ubiquitination targets activated PTKs for degradation either by facilitating their endocytic sorting into lysosomes or by promoting their proteasomal degradation. This mechanism also targets PTK signaling intermediates that become associated with Cbl proteins in a PTK activation-dependent manner. Cellular and animal studies have established that the relatively broadly expressed mammalian Cbl family members Cbl and Cbl-b play key physiological roles, including their critical functions to prevent the transition of normal immune responses into autoimmune disease and as tumor suppressors; the latter function has received validation from human studies linking mutations in Cbl to human leukemia. These newer insights together with embryonic lethality seen in mice with a combined deletion of Cbl and Cbl-b genes suggest an unappreciated role of the Cbl family proteins, and by implication the ubiquitin-dependent control of activated PTKs, in stem/progenitor cell maintenance. Future studies of existing and emerging animal models and their various cell lineages should help test the broader implications of the evolutionarily-conserved Cbl family protein-mediated, ubiquitin-dependent, negative regulation of activated PTKs in physiology and disease.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23085373      PMCID: PMC3628764          DOI: 10.1016/j.bbamcr.2012.10.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  218 in total

1.  Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl.

Authors:  Hao Dou; Lori Buetow; Andreas Hock; Gary J Sibbet; Karen H Vousden; Danny T Huang
Journal:  Nat Struct Mol Biol       Date:  2012-01-22       Impact factor: 15.369

2.  Genetic reconstitution of autoimmune type 1 diabetes with two major susceptibility genes in the rat.

Authors:  Norihide Yokoi; Chihiro Hayashi; Yuuka Fujiwara; He-Yao Wang; Susumu Seino
Journal:  Diabetes       Date:  2007-02       Impact factor: 9.461

3.  Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking.

Authors:  P Burke; K Schooler; H S Wiley
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

4.  Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.

Authors:  Paul Timpson; Danielle K Lynch; Daniel Schramek; Francesca Walker; Roger J Daly
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

Review 5.  New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades.

Authors:  K L Pierce; L M Luttrell; R J Lefkowitz
Journal:  Oncogene       Date:  2001-03-26       Impact factor: 9.867

6.  c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action.

Authors:  Juan C Molero; Thomas E Jensen; Phil C Withers; Michelle Couzens; Herbert Herzog; Christine B F Thien; Wallace Y Langdon; Ken Walder; Maria A Murphy; David D L Bowtell; David E James; Gregory J Cooney
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

7.  C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus.

Authors:  Kevin Wilhelmsen; Steve Burkhalter; Peter van der Geer
Journal:  Oncogene       Date:  2002-02-07       Impact factor: 9.867

8.  Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival.

Authors:  Yi Wang; Steven Pennock; Xinmei Chen; Zhixiang Wang
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 9.  Janus kinases in immune cell signaling.

Authors:  Kamran Ghoreschi; Arian Laurence; John J O'Shea
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

10.  Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323.

Authors:  M L Lupher; N Rao; N L Lill; C E Andoniou; S Miyake; E A Clark; B Druker; H Band
Journal:  J Biol Chem       Date:  1998-12-25       Impact factor: 5.157

View more
  99 in total

Review 1.  Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System.

Authors:  Mainak Guharoy; Pallab Bhowmick; Peter Tompa
Journal:  J Biol Chem       Date:  2016-02-05       Impact factor: 5.157

2.  Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.

Authors:  Scott A Nadeau; Wei An; Bhopal C Mohapatra; Insha Mushtaq; Timothy A Bielecki; Haitao Luan; Neha Zutshi; Gulzar Ahmad; Matthew D Storck; Masashi Sanada; Seishi Ogawa; Vimla Band; Hamid Band
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

3.  In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs).

Authors:  Nobumichi Ohoka; Keiichiro Okuhira; Masahiro Ito; Katsunori Nagai; Norihito Shibata; Takayuki Hattori; Osamu Ujikawa; Kenichiro Shimokawa; Osamu Sano; Ryokichi Koyama; Hisashi Fujita; Mika Teratani; Hirokazu Matsumoto; Yasuhiro Imaeda; Hiroshi Nara; Nobuo Cho; Mikihiko Naito
Journal:  J Biol Chem       Date:  2017-02-02       Impact factor: 5.157

4.  Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders.

Authors:  Basem M William; Wei An; Dan Feng; Scott Nadeau; Bhopal C Mohapatra; Matthew A Storck; Vimla Band; Hamid Band
Journal:  Hematology       Date:  2015-07-15       Impact factor: 2.269

Review 5.  Role of E3 ubiquitin ligases in gastric cancer.

Authors:  Ya-Chao Hou; Jing-Yu Deng
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

6.  Fibroblast growth factor signaling in myofibroblasts differs from lipofibroblasts during alveolar septation in mice.

Authors:  Stephen E McGowan; Diann M McCoy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-02       Impact factor: 5.464

7.  Modeling CBL activating mutations in vivo.

Authors:  Stanley Chun-Wei Lee; Omar Abdel-Wahab
Journal:  Blood       Date:  2017-04-13       Impact factor: 22.113

8.  Bacterial Protein Reshapes Host Defense toward Antiviral Responses.

Authors:  Hyungjin Eoh; Jae U Jung
Journal:  Mol Cell       Date:  2018-08-16       Impact factor: 17.970

9.  Glucocorticoid regulates TrkB protein levels via c-Cbl dependent ubiquitination: a decrease in c-Cbl mRNA in the prefrontal cortex of suicide subjects.

Authors:  Chirayu Pandya; Ammar Kutiyanawalla; Gustavo Turecki; Anilkumar Pillai
Journal:  Psychoneuroendocrinology       Date:  2014-04-06       Impact factor: 4.905

Review 10.  Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.

Authors:  Byung Min Chung; Eric Tom; Neha Zutshi; Timothy Alan Bielecki; Vimla Band; Hamid Band
Journal:  World J Clin Oncol       Date:  2014-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.